Recent News

• 05.20.2025 - Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders
• 05.20.2025 - Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders
• 05.15.2025 - 2025 BIONANO FIRST QUARTER FINANCIAL RESULTS CALL
• 05.15.2025 - 2025 BIONANO FIRST QUARTER FINANCIAL RESULTS CALL
• 05.14.2025 - Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress
• 05.14.2025 - Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress
• 05.07.2025 - Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025
• 05.07.2025 - Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025
• 05.02.2025 - International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers
• 05.02.2025 - International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

Recent Filings

• 05.14.2025 - 8-K Current report
• 05.14.2025 - EX-99.1 EX-99.1
• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.28.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.28.2025 - ARS Annual Report to Security Holders
• 04.28.2025 - DEF 14A Other definitive proxy statements
• 04.18.2025 - PRE 14A Other preliminary proxy statements